Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>On May 9, 2025, Soligenix, Inc. (SNGX) announced financial results for the first quarter of 2025 and provided a business update.</li><li>Enrollment continues in the confirmatory Phase 3 trial of HyBryte in patients with cutaneous T cell lymphoma (CTCL).</li><li>We anticipate topline results from this study in 2026.</li></ul>

On May 9, 2025, Soligenix, Inc. (SNGX) announced financial results for the first quarter of 2025 and provided a business update.Enrollment continues in the confirmatory Phase 3 trial of HyBryte in patients with cutaneous T cell lymphoma (CTCL).We anticipate topline results from this study in 2026.

SNGX: Enrollment Continues in Confirmatory Phase 3 Trial of HyBryte  in CTCL 